ArticleBlood advances2026

Delayed ADAMTS13 normalization in caplacizumab/PEX-treated patients associated with anti-ADAMTS13 IgG antibody boosting.

Nithya Prasannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.